The current prospects for neutrophil transfusions for the treatment of granulocytopenic infected patients (Q33835125)

29 July 2017

1 reference

title

The current prospects for neutrophil transfusions for the treatment of granulocytopenic infected patients (English)

1 reference

29 July 2017

Price TH

1

1 reference

29 July 2017

publication date

1 January 2000

1 reference

Transfusion Medicine Reviews

29 July 2017

published in

1 reference

29 July 2017

volume

14

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

2-11

1 reference

Management of fever in patients with cancer and treatment-induced neutropenia

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

Renewed interest in granulocyte transfusion therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

Nosocomial pneumonia in patients having bone marrow transplant attributable mortality and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripheral stem cell transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

Filtration leukapheresis for granulocyte transfusion therapy. Clinical and laboratory studies

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

Successful granulocyte transfusion therapy for gram-negative septicemia. A prospectively randomized controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

A controlled study of the efficacy of granulocyte transfusions in patients with neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

Normal granulocyte transfusion therapy: treatment of septicemia due to gram-negative bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

A Randomized Clinical Trial of Granulocyte Transfusions for Infection in Acute Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

Therapeutic granulocyte transfusions for documented infections. A controlled trial in ninety-five infectious granulocytopenic episodes

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

Review: granulocyte colony-stimulating factor--role and relationships in infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

Granulocyte transfusions in treatment of infections in patients with acute leukaemia and aplastic anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

Meta-analysis of clinical studies of the efficacy of granulocyte transfusions in the treatment of bacterial sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

Polymorphonuclear leukocyte transfusion for the treatment of sepsis in the newborn infant.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

An analysis of quantitative relationships of granulocyte transfusion therapy in canines

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

Neutrophil kinetics in man

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

Neutrophil (granulocyte) transfusions in the new millennium

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

The growth of mouse bone marrow cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

Cytokine receptors in congenital hematopoietic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

Chronic neutropenia. A new canine model induced by human granulocyte colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

Granulocyte Colony‐Stimulating Factor Administered In Vivo Augments Neutrophil‐Mediated Activity against Opportunistic Fungal Pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

Expression of neutrophil antigens after 10 days of granulocyte-colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

Collection and transfusion of granulocyte concentrates from donors primed with granulocyte stimulating factor and response of myelosuppressed patients with established infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

G-CSF stimulated donor granulocyte collections for prophylaxis and therapy of neutropenic sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

Transfusions of granulocyte-colony-stimulating factor-mobilized granulocyte components to allogeneic transplant recipients: analysis of kinetics and factors determining posttransfusion neutrophil and platelet counts

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

Evaluation and comparison of three mobilization methods for the collection of granulocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

A comparative trial of granulocyte-colony-stimulating factor and dexamethasone, separately and in combination, for the mobilization of neutrophils in the peripheral blood of normal volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

Neutrophil transfusions: kinetics and functions of neutrophils mobilized with granulocyte-colony-stimulating factor and dexamethasone

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

Indium-labeled white blood cells apheresed from donors receiving G-CSF localize to sites of inflammation when infused into allogeneic bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

Blood center perspective of granulocyte transfusions: future applications

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

Alloimmunization after granulocyte transfusions

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

Splenic Extramedullary Hematopoiesis in a Patient Receiving Intermittently Administered Granulocyte ColonyStimulating Factor

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

Neurological disturbances due to filgrastim

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

Reversible thyroid dysfunction with filgrastim

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

Exacerbation of pseudogout by granulocyte colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

Granulocyte transfusion: stimulation of low dose granulocyte colony-stimulating factor in donors for leukapheresis.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980111-X

7 January 2021

10.1016/S0887-7963(00)80111-X

Identifiers

DOI

1 reference

29 July 2017

1 reference